SC COBRE: HUMAN ALKALINE CERAMIDASE REGULATION OF ANGIOGENESIS
SC COBRE:人体碱性神经酰胺酶对血管生成的调节
基本信息
- 批准号:7610445
- 负责人:
- 金额:$ 6.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-08-01 至 2008-06-30
- 项目状态:已结题
- 来源:
- 关键词:ApoptosisBlood VesselsBlood capillariesCeramidaseCeramidesChronicComputer Retrieval of Information on Scientific Projects DatabaseDevelopmentDiabetic RetinopathyEndothelial CellsEnzymesFamilyFundingG-Protein-Coupled ReceptorsGrantGrowthGrowth FactorHumanHydrolysisInflammationInstitutionInterventionLeadLipidsMediatingMetabolismObject AttachmentOrganPathologyPlayProcessRegulationResearchResearch PersonnelResourcesRheumatoid ArthritisRoleSolid NeoplasmSourceSphingolipidsSphingosineSphingosine-1-Phosphate ReceptorTimeTumor AngiogenesisUnited States National Institutes of HealthWound Healinganalogangiogenesiscapillarychemokinecytokineinhibitor/antagonist
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Angiogenesis, the process of formation of new capillaries from preexisting blood vessels, is essential for the proper organ development and tissue repair. However, uncontrollable angiogenesis may lead to pathologies such as chronic inflammation, diabetic retinopathy, rheumatoid arthritis, and growth of solid tumors. Angiogenesis is coordinately regulated by cytokines, chemokines, growth factors, and inhibitors. In addition to these proteinaceous factors, several lipid factors have been shown to play an important role in mediating angiogenesis. Prominent among them are sphingosine-1-P (S1P) and its analogs which potentiates growth factor-induced angiogenesis by bonding to G protein coupled receptors of the Edg receptor family. S1P is a metabolite of sphingolipids. It is generated from sphingosine through the action of sphingosine kianse. Sphingosine in turn is generated from hydrolysis of ceramide through the action of ceramidases. More recently, several studies demonstrate that ceramide induces growth arrest and apoptosis of endothelial cells. These results suggest that regulation of metabolism of sphingolipids may control angiogenesis. Our results for the first time demonstrate that the human alkaline phytoceramidase is a key enzyme that regulates the levels of ceramides and the analog of S1P, dihdyrosphingosine-1-P. This establishes the human alkaline phytoceramidase as a potential target for chemotherapeutic interventions of tumor angiogenesis and growth.
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
血管生成是从原有血管形成新毛细血管的过程,对于器官的正常发育和组织修复至关重要。然而,不可控制的血管生成可能导致病理学,如慢性炎症、糖尿病视网膜病变、类风湿性关节炎和实体瘤的生长。血管生成受细胞因子、趋化因子、生长因子和抑制剂的协同调节。除了这些蛋白质因子外,几种脂质因子已被证明在介导血管生成中起重要作用。其中突出的是鞘氨醇-1-P(S1P)及其类似物,其通过与Edg受体家族的G蛋白偶联受体结合来增强生长因子诱导的血管生成。S1P是鞘脂的代谢产物。它是由鞘氨醇通过鞘氨醇激酶的作用产生的。鞘氨醇又通过神经酰胺酶的作用由神经酰胺水解产生。最近,一些研究表明,神经酰胺诱导内皮细胞的生长停滞和凋亡。这些结果表明,调节鞘脂代谢可能控制血管生成。我们的研究结果首次表明,人类碱性植物神经酰胺酶是一种关键酶,调节神经酰胺和类似物的S1P,二氢鞘氨醇-1-P的水平。这建立了人类碱性植物神经酰胺酶作为一个潜在的目标化疗干预肿瘤血管生成和生长。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CUNGUI MAO其他文献
CUNGUI MAO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CUNGUI MAO', 18)}}的其他基金
Role of ACER2 in cancer chemoresistance and metastasis
ACER2在癌症化疗耐药和转移中的作用
- 批准号:
10650378 - 财政年份:2022
- 资助金额:
$ 6.87万 - 项目类别:
Role for Sphingosine Kinase 1 in Serine Deprivation
鞘氨醇激酶 1 在丝氨酸剥夺中的作用
- 批准号:
10004160 - 财政年份:2018
- 资助金额:
$ 6.87万 - 项目类别:
ROLE FOR ALKALINE CERAMIDASE 1 (ACER1) IN SKIN CANCER
碱性神经酰胺酶 1 (ACER1) 在皮肤癌中的作用
- 批准号:
8360387 - 财政年份:2011
- 资助金额:
$ 6.87万 - 项目类别:
ROEL FOR ALKALINE CERAMIDASE 1 (ACER1) IN SKIN CANCER
ROEL 用于治疗皮肤癌的碱性神经酰胺酶 1 (ACER1)
- 批准号:
8168053 - 财政年份:2010
- 资助金额:
$ 6.87万 - 项目类别:
SC COBRE: HUMAN ALKALINE PHYTOCERAMIDASE REGULATION OF ANGIOGENESIS
SC COBRE:人体碱性植物神经酰胺酶对血管生成的调节
- 批准号:
7381850 - 财政年份:2006
- 资助金额:
$ 6.87万 - 项目类别:
相似海外基金
A methodology to connect functionalized gonadal constructs to a chick embryo through mechanically induced blood vessels from an egg
一种通过鸡蛋机械诱导血管将功能化性腺结构连接到鸡胚胎的方法
- 批准号:
24K15741 - 财政年份:2024
- 资助金额:
$ 6.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
All-in-One Smart Artificial Blood Vessels
一体化智能人造血管
- 批准号:
EP/X027171/2 - 财政年份:2024
- 资助金额:
$ 6.87万 - 项目类别:
Fellowship
Development of nextgeneration cellular artificial blood vessels for coronary artery bypass surgery using bio-3D printer
使用生物 3D 打印机开发用于冠状动脉搭桥手术的下一代细胞人造血管
- 批准号:
23H02991 - 财政年份:2023
- 资助金额:
$ 6.87万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
ealization of navigation surgery by automatic recognition of stomach and surrounding blood vessels using artificial intelligence
利用人工智能自动识别胃及周围血管,实现导航手术
- 批准号:
23K07176 - 财政年份:2023
- 资助金额:
$ 6.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Realtime observation and optical control of living microbial probes in blood vessels
血管内活微生物探针的实时观察和光学控制
- 批准号:
23H00551 - 财政年份:2023
- 资助金额:
$ 6.87万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Creation of a technique for visualization of stress concentration in blood and blood vessels by combined measurement of photoelasticity and ultrasonic Doppler velocimetry
通过光弹性和超声多普勒测速的组合测量,创建了一种可视化血管中应力集中的技术
- 批准号:
23H01343 - 财政年份:2023
- 资助金额:
$ 6.87万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Shear stress-activated synthetic cells for targeted drug release in stenotic blood vessels
剪切应力激活合成细胞用于狭窄血管中的靶向药物释放
- 批准号:
10749217 - 财政年份:2023
- 资助金额:
$ 6.87万 - 项目类别:
Creation of 3D tissue culture system integrated with blood vessels and autonomic nerves
打造血管与植物神经融合的3D组织培养系统
- 批准号:
23H01827 - 财政年份:2023
- 资助金额:
$ 6.87万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Biological function of osteoporotic drugs on bone-specific blood vessels and perivascular cells
骨质疏松药物对骨特异性血管和血管周围细胞的生物学功能
- 批准号:
22K21006 - 财政年份:2022
- 资助金额:
$ 6.87万 - 项目类别:
Grant-in-Aid for Research Activity Start-up














{{item.name}}会员




